NeuroBio
  • Home
  • About Us
    • Our Science
    • Our Pipeline
    • Neuro-Bio Assets
  • Our People
    • Board
    • Management
    • Science Team
    • Science Advisory Board
    • Company Organogram
  • Publications
  • Investors
    • Hear from our Investors
    • FAQ’s
  • News
    • Supporters
  • Work With Us
    • Careers
    • Industrial Placements
  • Contact
Select Page
Baroness Greenfield’s Presentation at Brain Innovation Days in Brussels – November 2024!

Baroness Greenfield’s Presentation at Brain Innovation Days in Brussels – November 2024!

BLOWING THE MIND, EXPANDING THE MIND & LOSING THE MIND The human brain becomes highly personalized after birth by the development of unique configurations of connections between the brain cells that characterize its subsequent growth, personalizing it into what we...
Neuro-Bio new publication – A Novel 14mer Peptide Inhibits Autophagic Flux via Selective  Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease

Neuro-Bio new publication – A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease

Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14...
Neuro-Bio new publication – A Novel 14mer Peptide Inhibits Autophagic Flux via Selective  Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease

Neuro-Bio new publication – Oxidative Stress Triggers a Pivotal Peptide Linked to Alzheimer’s Disease

Our team has demonstrated that oxidative stress, triggered by high glucose, increases T14 peptide levels in vitro and reduces cell viability. The cyclic form of T14, NBP14, blocked these toxic effects, suggesting its potential as a therapeutic agent. These findings...
Neuro-Bio is joining the newly formed Employer Advisory Board at Nottingham Trent University and the Biosciences Department

Neuro-Bio is joining the newly formed Employer Advisory Board at Nottingham Trent University and the Biosciences Department

Sara Garcia Ratés, CSO at Neuro-Bio, will be representing Neuro-Bio together with members of other industries such Big Pharma in this collaboration of academia and industry. The board will provide advice and support to develop the University curriculum, initiate more...
Baroness Greenfield is speaking at the Brain Innovation Day Conference in Brussels – November 2024!

Baroness Greenfield is speaking at the Brain Innovation Day Conference in Brussels – November 2024!

The 4th edition of the Brain Innovation Days, organised by the European Brain Council, will take place on 13-14 November 2024 in Brussels, Belgium. The aim of the event is to bring the wider brain ecosystem together to foster dialogue,...
Baroness Greenfield speaks at the Longevity Nation 2024 Conference – October 2024!

Baroness Greenfield speaks at the Longevity Nation 2024 Conference – October 2024!

Baroness Greenfield spoke online at the Longevity Nation Conference on 28th October 2024, where she spoke about a novel mechanism underlying ageing. Click here to read more about the conference
« Older Entries
Next Entries »

LATEST NEWS

  • CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
  • CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
  • Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!
  • Our CSO Sara Garcia Rates & Project Development Manager, Bethany Watkinson, will be attending the MediWales (BioWales) event on Thursday 5th February
  • Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield is attending the “Inspire and Innovate with wise+ (Women in Innovation, Science & Engineering)” at the Novartis Basel Campus

TOPICS

  • Latest News
  • Media

© Neuro-Bio 2025

  • Instagram
© Neuro-Bio 2025